GW26-e2296 Structure, Detect and Evaluate a Tissue-Engineered 3D Cardiac Model Based on Decellularized Heart Scaffold In Vitro  by Lu, Yingjin et al.
J O U R N A L O F T H E A M E R I C A N C O L L E G E O F C A R D I O L O G Y , V O L . 6 6 , N O . 1 6 , S U P P L S , 2 0 1 5 C1BASIC ANDTRANSLATIONAL
MEDICINEBASIC RESEARCH OF CARDIOVASCULAR DISEASE
GW26-e0102
Loss of Angiotensin-Converting Enzyme 2 Exacerbates Renal Inﬂammation
and Injury in the Apolipoprotein E-Deﬁcient Mice
Jiuchang Zhong,1,2 Haiyan Jin,1,3 Zhenzhou Zhang,1,2 Laijiang Chen,1,2
Ran Xu,1,2 Yingle Xu,1 Pingjin Gao,1,2 Dingliang Zhu1,2
1State Key Laboratory of Medical Genomics, Ruijin Hospital, Shanghai
Jiao Tong University School of Medicine, Shanghai Institute of
Hypertension, China; 2Institute of Health Sciences, Shanghai Institute
for Biological Sciences, Chinese Academy of Sciences, China;
3Department of Mental Health, Ruijin Hospital Afﬁliated to Shanghai
Jiao Tong University School of Medicine, China
OBJECTIVES Clinical trial evidence indicates that atherosclerosis is
considered one of the major risk factors for the chronic kidney dis-
eases (CKD) and the blockade of renin-angiotensin system (RAS) has
been shown to delay the progression of CKD to end-stage renal dis-
eases and reduce renal events in patients. Angiotensin-converting
enzyme 2 (ACE2) is known as a negative regulator of the RAS, but
its role in atherosclerotic renal injury are poorly understood. We
hypothesized that ACE2 would exert beneﬁcial effects on renal injury
in apolipoprotein E (ApoE)-knockout (KO) mice.
METHODS The 3-month-old wild-type (WT), ApoEKO, ACE2KO, and
ACE2/ApoE double-KO mice were used in this study. Systolic blood
pressure (SBP) level of mouse wasmeasured non-invasively using the tail-
cuff method. We examined changes in pro-inﬂammatory cytokines/
chemokines and adhesion molecules, renal tubule and glomerulus ultra-
structure and pathological signaling assessed by real-time PCR, Western
blotting, and transmission electron microscope analyses, respectively.
RESULTS Compared to WT control mice, plasma total cholesterol
(CHO) and triacylglycerol (TG) concentrations were elevated in both
the ApoEKO mice and ACE2/ApoE double-KO mice (P<0.05, respec-
tively). ACE2 deﬁciency was linked with increased circulating Ang II
levels and a modest elevation in SBP levels in both the ACE2KO and
ACE2/ApoE double-KO mice. Compared with the ApoEKO kidneys, the
level of pro-inﬂammatory cytokines/chemokines and adhesion mole-
cules were increased in the ACE2/ApoE double-KO kidneys, including
interleukin (IL)-1beta, IL-6, tumor necrosis factor-alpha (TNF-alpha),
TNFRSF1A, RANTES, and intercellular adhesion molecule 1. Renal
dysfunction and ultrastructure injury were aggravated in the ApoE/
ACE2 double-KO mice associated with increases of plasma creatinine
and blood urea nitrogen levels (P<0.01, respectively). However, ACE2
deﬁciency had no effect on renal TNFRSF1B expression and circu-
lating lipid levels in the ACE2/ApoE double-KO mice (P>0.05,
respectively).
CONCLUSIONS Loss of ACE2 exacerbates kidney inﬂammation and
adverse renal injury in the ApoE-deﬁcient mice via activation of the TNF-
alpha/TNFRSF1A signaling pathway. These observations indicate detri-
mental effect of ACE2 deﬁciency on inﬂammation and renal dysfunction
and point to ACE2 as a novel target for kidney-protective therapies. Stra-
tegies aimed at enhancing ACE2 action may have important therapeutic
potential for atherosclerotic renal injuryandCKD.Thisworkwas supported
by Training Program of the National Major Research Plan (91339108), the
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OBJECTIVES To determine whether triglyceride/high-density lipoprotein
cholesterol ratio (TG/HDL-C), which has been shown to be an indicatorof the metabolic syndrome (MetS) and insulin resistance (IR), can predict
cardiovascular risk factors in the Chinese Han population in Xinjiang.
METHODS The Cardiovascular Risk Survey (CRS) was conducted from
October 2007 to March 2010. A total of 14618 representative partici-
pants were selected using a four-stage stratiﬁed sampling method. A
total of 5757 Han participants were included in the study. The present
statistical analysis was restricted to the 5595 Han subjects who had
complete anthropometric data. The sensitivity, speciﬁcity, and dis-
tance on the receiver operating characteristic (ROC) curve in each
TG/HDL level were calculated. The shortest distance in the ROC
curves was used to determine the optimal cutoff of the TG/HDL-C
ratio for detecting cardiovascular risk factors.
RESULTS The prevalence of hypertension, hypercholesterolemia and
hypertriglyceridemia were higher with higher TG/HDL-C ratio for both
men and women. The TG/HDL-C ratio was positively associated with
systolic blood pressure, diastolic blood pressure and serum concen-
trations of total cholesterol. The optimal TG/HDL-C ratio cutoffs for
predicting hypertension, dyslipidemia, diabetes and  two of these
risk factors for Han adults in Xinjiang were 1.3, 1.3, 1.4, 1.4 in men and
0.9, 1.0, 1.0, 1.1 in women, respectively.
CONCLUSIONS The evaluation of TG/HDL-C ratio should be consid-
ered for one of cardiovascular risk factor predictors among Han adults
in Xinjiang.
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OBJECTIVES Recently, renal sympathetic nerve (RSN) has become a
hot target for therapeutic intervention in several cardiovascular dis-
eases, including ventricular arrhythmias. However, the role of RSN in
the modulation of ventricular electrophysiological characteristics is
still poorly understood. The present study aimed to evaluate the ef-
fect of RSN activation (RSN-A) or denervation (RSN-D) on ventricular
electrophysiology.
METHODS Twenty-one dogs were randomly assigned into RSN-A
group (n¼8), RSN-D group (n¼8) and control group (n¼5). Animals in
RSN-A group received 3 hours of high frequency stimulation (20 Hz, 2
ms duration) at the voltage required to increase the systolic blood
pressure by 10% to simulate a hyperactive state of RSN. RSN-D was
achieved by ablating bilateral renal nerves. High frequency stimula-
tion (20 Hz, 2 ms duration, 15 mA, 60s) was applied before and after
each ablation to conﬁrm the adequacy of denervation. Ventricular
electrophysiological characteristics were measured at baseline and
after interventions in each group.
RESULTS Both RSN-A and RSN-D signiﬁcantly prolonged ventricular
effective refractory period (ERP) (RSN-A group: 174  12 vs 192  15 ms;
RSN-D group: 176  10 vs 190 11 ms, p <0.05 for both), action potential
duration (APD90) (RSN-A group: 219  13 vs 240  16 ms; RSN-D group:
222  11 vs 238 9 ms, p <0.05 for both), and QT interval (RSN-A group:
226  7 vs 249  9 ms; RSN-D group: 227  8 vs 246  8 ms, p <0.05 for
both). However, RSN-A signiﬁcantly increased corrected QT interval
(QTc) (354  11 vs 379  15 ms, p <0.05), while RSN-D did not affect it
(350  9 vs 359  13, p >0.05). In addition, RSN-A signiﬁcantly increased
T-peak to T-end (Tp-e) interval (an indicator highly correlated to the
dispersion of repolarization) (61  4 vs 85  8 ms, p <0.05), while RSN-D
decreased it (63  5 vs 52  6 ms, p <0.05). However, no signiﬁcant
electrophysiological change was detected in the ﬁve control animals.
CONCLUSIONS RSN-A and RSN-D cause different effects on ventric-
ular electrophysiological characteristics. These results suggest that
RSN may play an important role in the modulation of ventricular
electrophysiology and arrhythmogenesis.
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OBJECTIVES Decellularized extracellular matrix that has naturally
occurred three-dimensional structure has been utilized in cardiac
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achieving the ultimate goal of engineering a functional heart, how-
ever, some challenges regarding the scaffold preparation and the
sources of seeding cells still need to be addressed. The purpose of this
study was to establish and optimized the methodology of decellular-
ized heart scaffold. It’s also expected to establish a platform for the
decellularied heart tissue-based scaffold evaluation in vitro.
METHODS The decellularized heart scaffold was prepared by coronary
perfusion. Histological staining, DNA content assay and scanning electron
microscopy (SEM) were performed to evaluate the decellularized heart
scaffold. Neonatal rat cardiac cells and rat bone marrow multipotent stro-
mal cells (rBMSCs), which have the potential to transdifferentiate into
cardiomyocytes, were adopted to serve as seed cells respectively to
construct a tissue-engineered 3D cardiac model. To improve the viability
of cells on 3D scaffold, rotary cell culture system (RCCS) was also applied
to enhance the mass transport during the cultivation in vitro. The tissue-
engineered 3D model was evaluated by histological staining, SEM as well
as quantitative real-time RT-PCR analysis.
RESULTS Both histological staining and SEM detection revealed that
decelluarized heart scaffold preserves the ultrastructural conforma-
tion of the heart with few nuclei. The DNA content of the scaffold was
1.640.03ng/mg, which is signiﬁcantly lower than that of the control
group (native heart tissue). Histological staining and SEM images
showed their good viability during the 3D culture. Majority of the
seeded neonatal rat cardiac cells or rBMSCs grow on the surface of the
scaffold under the static culture condition. By contrast, a number of
cells distributing within the scaffolds were observed in the dynamic
cultures, indicating its good mass transport and microenvironment for
cell growth. Quantitative real-time RT-PCR analysis revealed that
expression level of transcript factor Gata 4 in the induced rBMSCs was
improved signiﬁcantly when compared to the negative control.
Similarly, the expression of gene Gata4 in the rBMSCs inoculated into
the decelluarized heart scaffold is much higher than that of the
negative control and the induced group (5-azacytidine-treated).
CONCLUSIONS The decellularized heart scaffolds prepared in the
present study were decellularized completely and preserved the full
extracellular matrix. It possesses not only good biocompatibility but
also naturally occurring three-dimensional structure. Moreover, our
research indicates that the decellularized heart scaffold might
potentially induce the differentiation of rBMSCs into cardiomyocytes.
Combined with the RCCS cultivation, the tissue-engineered 3D cardiac
model based on decellularized heart scaffold can better simulate the
microenvironment in vivo and might potentially be utilized for car-
diac tissue engineering.
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OBJECTIVES Red cell distribution width (RDW) might be a novel
biomarker that reﬂects multiple physiological impairments related to
atherosclerosis and acute coronary syndrome (ACS). We conducted
this systematic review and meta-analysis to evaluate the association
of RDW between risk of major adverse cardiovascular Events (MACEs),
all-cause and cardiovascular mortality in ACS patients.
METHODS Relevant studies were searched and identiﬁed in the
Cochrane Library, PubMed and Embase databases. English-language
studies that reported risk estimates for RDW and MACEs, all-cause
and cardiovascular mortality were included. Data were extracted
regarding the characteristics and clinical outcomes, and a quality
assessment was conducted. Results were extracted for the average
RDW level, and meta-analyses were carried out using random effects
models.
RESULTS We collected 14 articles. 9 investigated the association
between RDW and all-cause mortality, 3 evaluated the association
between RDW and risk of cardiovascular mortality, and 7 reported the
association between RDW and risk of MACEs. We found that RDW was
associated with a signiﬁcantly increased risk of all-cause mortality
(HR:3.372; 95%CI:2.014 - 5.645; P <0.001), cardiovascular mortality
(HR: 2.342; 95%CI: 1.769 - 3.100; P <0.001) and MACEs (HR: 2.120; 95%
CI: 1.515-2.965; P <0.001;).
CONCLUSIONS The meta-analysis indicates that RDW signiﬁcantly
increased the risk of MACEs, all-cause and cardiovascular mortality
in ACS patients.GW26-e5367
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OBJECTIVES Recent evidence implicates SIRT3 as a central regulator
of mitochondrial redox balance and metabolic homeostasis but the
contribution of SIRT3 to vascular function remains unknown. The aim
of this study was to investigate the role of SIRT3 in obesity-induced
endothelial insulin resistance and subsequent vascular dysfunction.
METHODS Both vascular response to insulin and SIRT3 expression
were detected in morbid obese human subjects undergoing bariatric
surgery and non-obese controls. Male SIRT3 knockout mice and wide
type littermates were fed with a standard chow diet or a high fat diet
(HFD) for 24 weeks.
RESULTS We found an impaired insulin-induced mesenteric vaso-
relaxation (82.468.5% vs. 54.936.46%, n¼8-12, P<0.05) and
concomitant a 50% reduced vascular SIRT3 expression in morbid obese
human subjects compared with non-obese controls. Downregulation of
SIRT3 either by siRNA or by palmitate excess treatment in cultured
human endothelial cells resulted in overproduction of mitochondrial
reactive oxygen species (mtROS) and impaired insulin signaling as
indicated by decreased phosphorylation of Akt and eNOS and subse-
quent reduced NO release. Additionally, obese mice induced by 24-week
HFD displayed an impaired endothelium-dependent vasorelaxation to
both insulin (40.68  3.68% vs. 64.98  2.85%, n ¼ 8, P < 0.01) and
acetylcholine (46.45  4.93% vs. 100.59  2.35%, n ¼ 6, P < 0.01), which
was further exacerbated by gene deletion of SIRT3 (P < 0.05). Moreover,
lentivirus-mediated restoration of vascular SIRT3 rescued HFD-induced
endothelial dysfunction in SIRT3 knockout mice (46.84  3.29% vs.
29.56  2.99%, n ¼ 6, P < 0.01 for response to insulin; 75.59  4.93% vs.
57.25  3.81%, n ¼ 6, P < 0.01 for response to acetylcholine). Elimination
of mtROS with MitoTEMPO not only restored insulin-stimulated
NO production in SIRT3 knockdown cells but also improved insulin-
induced vasorelaxation in SIRT3 knockout mice fed with HFD.
CONCLUSIONS Our ﬁndings suggest that SIRT3 positively regulates
endothelial insulin sensitivity and show that SIRT3 deﬁciency and
resultant mtROS overproduction contribute to vascular dysfunction in
obesity.
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OBJECTIVES Diabetes mellitus (DM) is one of the greatest public
health threats in modern societies. And among all the diabetic com-
plications, diabetic cardiomyopathy (DCM) has been recognized as the
leading cause of morbidity and mortality. Thus, the elucidation of
pathological mechanisms in DCM is urgently needed, so as to develop
novel therapies. Fenoﬁbrate (FF) is a peroxisome proliferator-acti-
vated receptor-a (PPARa) agonist. It has long been used clinically to
lower lipid levels for about three decades. Here we tested whether FF
can be repurposed to prevent diabetic cardiomyopathy (DCM) for type
1 diabetes, and delineated the mechanism of its action.
METHODS Streptozotocin (STZ) was used to induce type 1 diabetes in
wild type C57BL/6J mice and ﬁbroblast growth factor 21 knock-out
(FGF21KO) mice, diabetic and age-matched control mice were then
treated with vehicle or FF by gavage every other day for 3 or 6 months.
After that we sacriﬁced the animal models and obtained heart tissue
for further study including western blot assay, real-time PCR, pa-
thology staining and so on. The H9c2 cardiac myoblast cells were used
for the in vitro study.
RESULTS FF prevented diabetes-induced cardiac dysfunction as well
as cardiac inﬂammation, oxidative stress and remodeling (PAI-1,
TNFa, 3NT, 4HNE, CTGF, TGFb), along with up-regulated cardiac
expression of FGF21 and sirtuin1 (Sirt1). In contrast to wild-type dia-
betic mice, FGF21-KO mice showed worse biochemical, pathological,
and functional changes of the heart following diabetes induction, and
failed to respond to FF treatment even though FF similarly lowered
systemic lipid proﬁle in both WT and FGF21-KO diabetic mice.
